Question 1

What specific benefits could ARISTA™ AH provide during my surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER clinical trial (NCT06822036). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to standard practices for reducing blood loss?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER clinical trial (NCT06822036). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects or risks associated with using ARISTA™ AH?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER clinical trial (NCT06822036). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my erectile function be monitored after the surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER clinical trial (NCT06822036). Contact the study team or your healthcare provider for specific answers.

Question 5

What will my participation involve in terms of visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER clinical trial (NCT06822036). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER clinical trial (NCT06822036). Contact the study team or your healthcare provider for specific answers.

EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER

What this study is about

EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER

What this study is about